TechSci Healthcare Industry Report

Increasing prevalence of  nosocomial infections and  unhygienic environmental conditions  are  expected to drive the India anti-fungal drugs market in the forecast period. According to TechSci Research report,  “ India Anti-Fungal Drugs Market  By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication (Candidiasis, Aspergillosis, Dermatophytosis, Mucormycosis, Others), By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection), By Route of Administration (Parenteral, Topical, Oral, Others), By End-User (Homecare, Hospitals, Clinics, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By Region, Competition Forecast & Opportunities, FY2027F” ,  India anti-fungal drugs market is expected  to reach USD1562.73 million by FY2027 and to grow with a double digit CAGR of 10.49% over the forecast period.   Fungi are defined as microorganisms which can cause variety of i...

  Increasing prevalence of  nosocomial infections and  unhygienic environmental conditions  are  expected to drive the India anti-fungal drugs market in the forecast period. According to TechSci Research report,  “ India Anti-Fungal Drugs Market  By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication (Candidiasis, Aspergillosis, Dermatophytosis, Mucormycosis, Others), By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection), By Route of Administration (Parenteral, Topical, Oral, Others), By End-User (Homecare, Hospitals, Clinics, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By Region, Competition Forecast & Opportunities, FY2027F” ,  India anti-fungal drugs market is expected  to reach USD1562.73 million by FY2027 and to grow with a double digit CAGR of 10.49% over the forecast period.   Fungi are defined as microorganisms which can cause varie...

  Increasing prevalence of  nosocomial infections and  unhygienic environmental conditions  are  expected to drive the India anti-fungal drugs market in the forecast period. According to TechSci Research report,  “ India Anti-Fungal Drugs Market  By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication (Candidiasis, Aspergillosis, Dermatophytosis, Mucormycosis, Others), By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection), By Route of Administration (Parenteral, Topical, Oral, Others), By End-User (Homecare, Hospitals, Clinics, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By Region, Competition Forecast & Opportunities, FY2027F” ,  India anti-fungal drugs market is expected  to reach USD1562.73 million by FY2027 and to grow with a double digit CAGR of 10.49% over the forecast period.   Fungi are defined as microorganisms which can cause varie...